Last updated on August 2019

LEMTRADA Pregnancy Registry in Multiple Sclerosis

Brief description of study

Primary Objective:

The primary goal of this registry is to assess the risk of spontaneous abortion in prospective enrolled women exposed to LEMTRADA for multiple sclerosis.

Secondary Objective:

The secondary goals of this registry is to assess maternal, fetal and infant outcome in women with multiple sclerosis, exposed to LEMTRADA.

Detailed Study Description

From enrollment during pregnancy up to 1 year after delivery for infant follow-up (maximum approximatively 20 months)

Clinical Study Identifier: NCT03774914

Find a site near you

Start Over


Belgium, Belgium
  Connect »